Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Worldwide Offices
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

TraceLink Named to RXinsider's 2026 Pharmacy500 for Powering Digital Network Orchestration Across the Regulated Pharmacy Supply Chain

This image opens in the lightbox

News provided by

TraceLink, Inc.

19 Feb, 2026, 15:00 GMT

Share this article

Share toX

Share this article

Share toX

The recognition highlights TraceLink's Business-to-Network Integrate-Once™ platform that enables end-to-end digitalization, interoperable compliance execution, and operational resilience at industry scale

Summary
TraceLink is recognized for delivering a unified, network-based platform that helps pharmacies and their trading partners orchestrate procure-to-pay through an Integrate-Once™ model, automate the identification and reconciliation of recalled products, and operationalize DSCSA regulatory requirements on an industrial-grade foundation designed for mission-critical, regulated processes.

BOSTON, Feb. 19, 2026 /PRNewswire/ -- TraceLink, the largest end-to-end digital network platform for intelligent supply chain orchestration, today announced it has been named to RXinsider's 2026 Pharmacy500 list for the third consecutive year. The Pharmacy500 recognizes companies whose solutions are driving meaningful operational impact across the U.S. pharmacy supply chain.

As pharmacies face increasing drug costs and drug shortages, higher transaction volumes, and growing operational pressure, TraceLink provides a Business-to-Network Integrate-Once™ model that links CMOs, brand manufacturers, wholesalers, logistics providers, health systems, and retail pharmacies through a shared digital infrastructure. Rather than relying on fragmented systems and point-to-point integrations, pharmacies operate regulated workflows—including procure-to-pay processes, DSCSA compliance, compliance exception management, and recall management—directly on the TraceLink network.

"Protecting patients today requires orchestration across many companies, people, processes, and systems. It requires dispensers and their suppliers to work together reliably at scale," said Shabbir Dahod, President and CEO of TraceLink. "Our platform helps pharmacies and health systems meet DSCSA requirements and orchestrate critical processes such as procure-to-pay and recalls management and move forward with confidence—so pharmacy teams can focus on patient care while the system handles the complexity behind the scenes."

Digitalizing the End-to-End Pharmacy Supply Chain on an Industrial-Grade Platform Built for Regulated Industries Like Healthcare
With full DSCSA interoperability enforcement now active, pharmacies face operational and financial risk when transaction systems fail to perform at scale. Product holds, inventory shortages, order management exceptions, shipment delays, reconciliation errors, and financial audit exposure directly impact product availability and patient safety.

TraceLink addresses these challenges by enabling pharmacies to digitalize workflows on a single network platform. This shared operational backbone allows pharmacies and their trading partners to operate in real time, coordinate across organizations, and maintain continuous visibility without fragmented systems or point-to-point integrations.

As a result of this network-based execution model, issues such as recalls or compliance exceptions are handled as part of normal operational execution—not as isolated emergency processes. Pharmacies gain faster product identification, more precise targeting, and coordinated partner response, helping to maintain continuity of care while minimizing operational disruption.

Orchestrating Execution at Scale Through an Industrial No-Code Platform
TraceLink's platform enables pharmacies to move beyond task-level automation to orchestrated execution across trading partners, systems, and regulatory processes.

Built on an industrial, governed no-code platform, pharmacies can orchestrate and adapt network-based workflows that support daily operations and high-impact events without custom development.

Solutions such as Multienterprise Information Network Tower (MINT), Process Orchestration for Empowered Teams (POET), and OPUS Reports and Dashboards operate as native, integrated components of this orchestration layer, enabling visibility, workflow coordination, and performance monitoring without siloed tooling. Critically, for IT teams with already-stretched work backlogs, all OPUS solutions also feature no-code configuration capability for business teams to quickly adapt workflows, user roles, permissions, and other settings to each organization's needs.

Looking ahead, TraceLink's platform architecture and end-to-end supply chain orientation are purpose-built to support governed digital AI agents operating alongside pharmacy teams, enabling responsible automation of high-volume compliance and operational tasks under human oversight.

Built for Pharmacy-Grade Reliability and Network Scale
TraceLink's platform is engineered to support always-on healthcare operations at scale:

  • 99.98%+ availability exceeded via always-on architecture in an active-active-active deployment.
  • 9+ billion EPCIS transactions processed across tens of billions of serialized items.
  • 310,000+ pre-integrated trading partners.
  • Proven performance during DSCSA enforcement milestones with 95% of transactions processed within 1 minute.
  • 73B+ commissioned serial numbers managed.
  • Top-tier ISO, SOC, and CyberVadis results—including zero nonconformances, zero exceptions, and a Platinum CyberVadis rating (993/1,000)—validating the security, compliance, and resilience of TraceLink's industrial-grade digital network platform.

This industrial-grade infrastructure enables pharmacies to operate with confidence as regulatory complexity and transaction volumes continue to increase.

Being named to RXinsider's 2026 Pharmacy500 reflects the trust pharmacies place in TraceLink to operate regulated supply chain processes at scale. By combining its B2N Integrate-Once™ model, orchestrated execution, and real-time operational visibility, TraceLink helps pharmacies reduce disruption, maintain continuity of care, and build resilient digital operations for the future. Learn how TraceLink is helping define the next era of pharmacy supply chain operations at https://www.tracelink.com/. 

About TraceLink
TraceLink Inc. is the largest end-to-end intelligent supply chain platform for life sciences and healthcare, enabling end-to-end orchestration by linking more than 291,000 healthcare and life sciences entities through its Business-to-Network Integrate-Once™ network. Leading companies trust TraceLink to deliver complete global digitalization, visibility, and traceability of healthcare products, ensuring that every patient receives the medicines they rely on, safely, securely, and on time. 

About RXinsider
Headquartered in West Warwick, Rhode Island, RXinsider is a pharmacist-founded marketing/communications (MARCOM) and market intelligence (INTEL) company focused on pharmacy operations and the companies supporting dispensing pharmacies. Through our publications, digital platforms, market research, and training resources, RXinsider educates pharmacy management and industry professionals on the products, services, and trends that impact pharmacy operations across the supply chain.

Logo - https://mma.prnewswire.com/media/1004729/TraceLink_Logo.jpg 

Modal title

Also from this source

TraceLink Unleashes New OPUS Capabilities to Accelerate Supply Chain Agility

TraceLink Unleashes New OPUS Capabilities to Accelerate Supply Chain Agility

TraceLink, the largest end-to-end digital network platform for intelligent orchestration of the supply chain, today announced the release of powerful ...

TraceLink Delivers Intelligent Productivity Gains with OPUS Platform Expansion

TraceLink Delivers Intelligent Productivity Gains with OPUS Platform Expansion

TraceLink, the largest end-to-end digital network platform for intelligent orchestration of the supply chain, today announced powerful new...

More Releases From This Source

Explore

Computer & Electronics

Computer & Electronics

Computer Software

Computer Software

Computer Software

Computer Software

Health Care & Hospitals

Health Care & Hospitals

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • PR Newswire Amplify™
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.